Cardiology Division, Severance Cardiovascular Hospital and Cardiovascular Research Institute (C.J.L., S.P.), Yonsei University College of Medicine, Seoul, Republic of Korea.
Division of Endocrinology and Metabolism (J.-Y.L., E.S.K., B.-S.C., Y.-h.L.), Yonsei University College of Medicine, Seoul, Republic of Korea.
Hypertension. 2022 Jan;79(1):218-229. doi: 10.1161/HYPERTENSIONAHA.121.17283. Epub 2021 Nov 15.
There are inconsistent results on the impacts of controlling blood pressure (BP) on the risk of dementia. We investigated the association between BP and risk of dementia subtypes by antihypertensive treatment and comorbidities. Using the Korean National Health Insurance Service-Health Screening Database from 2009 to 2012, a total of 4 522 447 adults aged 60+ years without a history of dementia were analyzed and followed up for a mean of 5.4 years. Individuals were classified according to their baseline systolic BP (SBP) and diastolic BP; SBP 130 to <140 mm Hg and diastolic BP 80 to <90 mm Hg were used as reference groups. The risk of overall dementia and probable Alzheimer disease was significantly higher in the SBP≥160 and lower SBP groups. These U-shaped associations were consistent regardless of antihypertensive use or comorbidities. The risk of probable vascular dementia (VaD) was not higher among lower SBP groups and increased gradually as SBP increased. Although there was a linear association between SBP and the risk of probable VaD in individuals not taking antihypertensives or without comorbidities, there was a U-shaped association in individuals taking antihypertensives or with comorbidities. Patterns of association between diastolic BP and risk of probable Alzheimer disease or probable VaD were similar to those with SBP, except for the risk of probable VaD in individuals taking antihypertensives. In conclusion, risks of probable Alzheimer disease and probable VaD were different among lower BP groups. Although the risk of dementia appears higher in people with lower BP receiving antihypertensives, this finding may be affected by comorbidities.
血压控制对痴呆风险的影响结果不一致。我们通过抗高血压治疗和合并症来研究血压与痴呆亚型风险之间的关系。使用韩国国家健康保险服务-健康筛查数据库,对 2009 年至 2012 年期间无痴呆病史的 4522447 名 60 岁以上成年人进行了分析,并随访了平均 5.4 年。根据基线收缩压(SBP)和舒张压将个体进行分类;SBP 为 130 至<140mmHg 和舒张压为 80 至<90mmHg 用作参考组。SBP≥160mmHg 和 SBP 较低组的总体痴呆和可能的阿尔茨海默病风险显著较高。无论是否使用抗高血压药物或合并症,这种 U 型关联都是一致的。较低 SBP 组发生可能的血管性痴呆(VaD)的风险并不高,并且随着 SBP 的增加而逐渐增加。虽然在未服用抗高血压药物或无合并症的个体中,SBP 与可能的 VaD 风险之间存在线性关联,但在服用抗高血压药物或有合并症的个体中存在 U 型关联。SBP 与可能的阿尔茨海默病或可能的 VaD 风险之间的关联模式与 SBP 相似,除了服用抗高血压药物的个体中可能的 VaD 风险。总之,较低 SBP 组发生可能的阿尔茨海默病和可能的 VaD 的风险不同。尽管服用抗高血压药物的血压较低的人患痴呆的风险似乎更高,但这一发现可能受到合并症的影响。